Considerations in the management of patients with philadelphia chromosome-positive chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

Hagop Kantarjian; Jorge Cortes

doi:10.1200/JCO.2010.33.9176

Considerations in the management of patients with philadelphia chromosome-positive chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

Hagop Kantarjian
, Jorge Cortes

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1512-1516
Number of pages	5
Journal	Journal of Clinical Oncology
Volume	29
Issue number	12
DOIs	https://doi.org/10.1200/JCO.2010.33.9176
State	Published - Apr 20 2011
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2010.33.9176

Cite this

@article{b563a4e4593d4bda97d2098ca96a3d16,

title = "Considerations in the management of patients with philadelphia chromosome-positive chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy",

author = "Hagop Kantarjian and Jorge Cortes",

year = "2011",

month = apr,

day = "20",

doi = "10.1200/JCO.2010.33.9176",

language = "English (US)",

volume = "29",

pages = "1512--1516",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "12",

}

TY - JOUR

T1 - Considerations in the management of patients with philadelphia chromosome-positive chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

AU - Kantarjian, Hagop

AU - Cortes, Jorge

PY - 2011/4/20

Y1 - 2011/4/20

UR - https://www.scopus.com/pages/publications/79954986886

UR - https://www.scopus.com/pages/publications/79954986886#tab=citedBy

U2 - 10.1200/JCO.2010.33.9176

DO - 10.1200/JCO.2010.33.9176

M3 - Comment/debate

C2 - 21422414

AN - SCOPUS:79954986886

SN - 0732-183X

VL - 29

SP - 1512

EP - 1516

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 12

ER -

Considerations in the management of patients with philadelphia chromosome-positive chronic myeloid leukemia receiving tyrosine kinase inhibitor therapy

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this